시장보고서
상품코드
1429506

세계의 고효능 원료의약품 시장 보고서(2024년)

HP (High Potency) APIs Global Market Report 2024

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

고효능 원료의약품 시장 규모는 향후 몇 년 동안 크게 성장할 것으로 예상됩니다. 2028년에는 연평균 성장률(CAGR) 9.3%로 363억 8,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안 예상되는 성장은 암 환자 수 증가, 정밀 의료에 대한 관심 증가, 고령화 인구의 지속적인 증가와 관련이 있을 수 있으며, 이 모든 것이 성장을 촉진하는 데 기여하고 있습니다. 예측 기간 동안 예상되는 주요 동향으로는 생산 시설 확장 및 인수합병과 같은 활동에 대한 전략적 집중, HPAPI 생산 강화를 위한 투자 확대에 대한 집중, API 제조에 인공지능(AI)을 접목하는 등의 전략적 집중이 있습니다. 환경적으로 지속가능한 제조 관행에 중점을 두고 혁신적인 신제품 출시에 주력하고 있습니다.

고효능 원료의약품 시장의 성장은 암 발병률 증가와 이에 따른 항암제 판매 증가에 의해 주도되고 있습니다. 암 발병률의 급격한 증가로 인해 항암제 연구 개발이 강화되고 있으며, 이에 따라 시장 수요가 증가하고 있습니다. 세계보건기구 산하 국제암연구소(IARC)의 보고서에 따르면, 2040년까지 전 세계 암 발병은 2,950만 명 증가하여 1,640만 명이 사망할 것으로 예상됩니다. 특히 암으로 인한 사망의 70%는 암과 관련이 있습니다. 중저소득 국가에서 발생합니다. 이에 따라 암 발병률 증가로 인해 고효능 원료의약품 시장의 수익이 증가할 것으로 예상됩니다.

암 치료 및 치료 강화를 위한 정부의 노력은 향후 고효능 원료의약품 시장의 성장을 촉진할 수 있는 여건을 조성하고 있습니다. 이러한 노력에는 암 진단을 받은 개인의 접근성, 경제성, 치료의 질을 향상시키기 위해 정부가 시행하는 정책, 자금 지원, 프로그램 등이 포함됩니다. 암 치료에서 고효능 원료의약품의 중요성은 특정 분자 경로를 표적으로 삼아 치료 효과를 높일 수 있는 능력에 있습니다. 2023년 9월 바이든 대통령이 발표한 '암 문샷 이니셔티브(Cancer Moonshot Initiative)'의 부활이 그 한 예입니다. 이 이니셔티브는 질병통제예방센터(CDC)의 지원을 받아 25년 내에 암으로 인한 사망률을 절반으로 낮추고 암에 대한 종합적인 지원을 제공하는 것을 목표로 하고 있습니다. 생존자와 그 가족. 그 결과, 암 치료 및 치료를 개선하기 위한 정부의 노력은 고효능 원료의약품 시장의 성장을 촉진하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

  • 고인플레이션이 시장에 미치는 영향
  • 우크라이나·러시아 전쟁이 시장에 미치는 영향
  • COVID-19에 의한 시장에 대한 영향

제5장 세계 시장 규모와 성장

  • 세계의 시장 성장 촉진요인과 억제요인
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 세계의 시장 규모 실적과 성장, 2018-2023년
  • 세계의 시장 규모 예측과 성장, 2023-2028년, 2033년

제6장 시장 세분화

  • 세계의 고효능 원료의약품 시장, 유형별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 혁신 HPAPI
  • 범용 HPAPI
  • 세계의 고효능 원료의약품 시장, 합성 유형별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 합성 HPAPI
  • 바이오테크놀러지 HPAPI
  • 세계의 고효능 원료의약품 시장, 치료 용도별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 종양학
  • 호르몬장애
  • 녹내장
  • 기타 치료 용도(호흡기질환, CVD, 당뇨병, 미용, 발기부전)

제7장 지역 및 국가 분석

  • 세계의 고효능 원료의약품 시장, 지역별, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 세계의 고효능 원료의약품 시장, 국가별, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 상황과 기업 개요

  • 고효능 원료의약품 시장 경쟁 상황
  • 고효능 원료의약품 시장 기업 개요
    • Merck KGaA
    • Pfizer, Inc
    • Thermo Fisher Scientific, Inc
    • Teva Pharmaceuticals
    • Lonza Group AG

제31장 기타 주요 및 혁신적인 기업

  • Sanofi(EUROAPI)
  • Corden Pharma International
  • Dr. Reddy's Laboratories Ltd.
  • Siegfried Holding AG
  • Novartis
  • Roche India
  • Arlak Biotech(India)
  • Healthkind Labs Pvt. Ltd
  • Swisschem Healthcare Pvt. Ltd
  • Apikos Pharma
  • Kolaz Biotech
  • Cstone Pharma(China)
  • Carsgen Therapeutics(China)
  • Jw Therapeutics(China)
  • Beigene(China)

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 인수합병

제35장 향후 전망과 가능성 분석

제36장 부록

ksm 24.03.21

High-potency APIs denote substances that, at very minimal doses, elicit a biological response. Traditionally, examples of HPAPIs include cytotoxic substances and sex hormones such as estrogen. While highly potent active pharmaceutical ingredients (HP APIs) in the market remain effective at significantly lower dosage levels compared to standard APIs, their potency presents distinctive handling challenges.

The primary categories within the high-potency APIs market are innovative HPAPI and generic HPAPI. Various synthesis types, including synthetic HPAPI and biotech HPAPI, find application in therapeutic areas such as oncology, hormonal disorders, glaucoma, and other medical fields such as respiratory disorders, cardiovascular disease (CVD), diabetes, cosmetology, and erectile dysfunction. Glaucoma comprises a group of eye diseases affecting the optic nerve, crucial for maintaining good vision.

The HP (high potency) APIs market research report is one of a series of new reports from The Business Research Company that provides HP (high potency) APIs market statistics, including HP (high potency) APIs industry global market size, regional shares, competitors with an HP (high potency) APIs market share, detailed HP (high potency) APIs market segments, market trends and opportunities, and any further data you may need to thrive in the HP (high potency) APIs industry. This HP (high potency) APIs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The hp (high potency) apis market size has grown strongly in recent years. It will grow from $23.39 billion in 2023 to $25.5 billion in 2024 at a compound annual growth rate (CAGR) of 9.0%. The expansion observed in the historical period can be ascribed to a heightened demand for oncology therapies, a growing focus of pharmaceutical companies on the production of high-potency active pharmaceutical ingredients (HPAPIs), an upsurge in healthcare awareness and expenditure, robust economic growth in emerging markets, and a rise in government initiatives.

The hp (high potency) apis market size is expected to see strong growth in the next few years. It will grow to $36.38 billion in 2028 at a compound annual growth rate (CAGR) of 9.3%. The anticipated growth in the forecast period can be linked to an increase in the number of cancer cases, a heightened emphasis on precision medicine, and the continuous growth of the ageing population, all contributing to driving the expansion. Major trends expected in the forecast period involve a strategic emphasis on activities such as expanding production facilities and engaging in mergers and acquisitions, a dedicated focus on augmenting investments to bolster HPAPI production, the incorporation of artificial intelligence (AI) in manufacturing APIs, an emphasis on environmentally sustainable manufacturing practices, and a concentration on launching new, innovative products.

The growth of the HP (high potency) APIs market is driven by the increasing number of cancer cases and the concurrent rise in sales of cancer drugs. The surge in cancer incidence is leading to heightened research and development efforts for anticancer drugs, consequently fueling the demand for the market. According to the International Agency for Research on Cancer (IARC) report by the World Health Organization, the global cancer burden is anticipated to witness an increase of 29.5 million new cases and 16.4 million deaths by 2040. Notably, 70% of cancer-related deaths occur in middle and low-income countries. As a result, the escalating prevalence of cancer is expected to boost revenues for the HP (high potency) APIs market.

Government initiatives aimed at enhancing cancer care and treatment are poised to drive the future growth of the HP (high potency) APIs market. These initiatives encompass policies, funding, and programs implemented by governments to enhance the accessibility, affordability, and quality of care for individuals diagnosed with cancer. The importance of High Potency (HP) APIs in cancer treatment lies in their ability to target specific molecular pathways, thereby enhancing the effectiveness of therapies. An example is the revival of the Cancer Moonshot Initiative unveiled by President Biden in September 2023. The initiative, supported by the Centers for Disease Control and Prevention (CDC), aims to halve the cancer death rate within 25 years and provide comprehensive support to cancer survivors and their families. Consequently, government initiatives to improve cancer care and treatment are propelling the growth of the HP (high potency) APIs market.

Companies operating in the HP (high potency) APIs market are adopting strategies such as expanding production facilities and engaging in mergers and acquisitions to maintain their competitive positions. In June 2022, MilliporeSigma, a global life science business based in the US, inaugurated a $65 million facility for the production of high-potency active pharmaceutical ingredients (HPAPI), with a specific focus on cancer treatments.

Major players in the HP (high potency) APIs market are actively pursuing strategic partnerships to drive market revenues. Collaborations offer various advantages, including access to new technology, expanded customer choice, global servicing capabilities, a collaborative global platform, and integrated services. In March 2023, CatSci Ltd., a UK-based provider of innovative process research and development services, partnered with AGC Pharma Chemicals Europe S.L.U. This collaboration enables customers to access a broad range of manufacturing technologies, including fluorination and bromination. It also facilitates AGC Pharma Chemicals' customers to benefit from expertise in state-of-the-art chemical development and analytical development.

In December 2021, SK Capital Partners, a US-based private investment firm, acquired a majority shareholding in SEQENS for an undisclosed amount. This strategic move positions SEQENS as a more potent and concentrated participant in the international markets for specialized ingredients and pharmaceutical solutions. Wavelength Pharmaceuticals, an existing SK Capital portfolio business that is a global manufacturer and developer of active medicinal ingredients, engaged in a combination concurrent with the acquisition. SEQENS, a France-based developer and manufacturer of custom High-Potency APIs, is a key player in this transformative development.

Major companies operating in the hp (high potency) apis market report are Merck KGaA, Pfizer, Inc., Thermo Fisher Scientific, Inc., Teva Pharmaceuticals, Lonza Group AG, Sanofi (EUROAPI), Corden Pharma International, Dr. Reddy's Laboratories Ltd., Siegfried Holding AG, Novartis, Roche India, Arlak Biotech (India), Healthkind Labs Pvt. Ltd., Swisschem Healthcare Pvt. Ltd., Apikos Pharma, Kolaz Biotech, Cstone Pharma (China), Carsgen Therapeutics (China), Jw Therapeutics (China), Beigene(China), Takeda Pharmaceuticals (Japan), Astellas Pharma Inc (Japan), Otsuka Pharmaceutical Co, Ltd (Japan), Legend Biotech Co (China), Abbott Laboratories, Vectura Group (U.K), Corex Logistics, Dokumeds, Medpace, Labcorp, Almedis (Russia), Neuca, Farmacol, Polska Grupa Farmaceutyczna, Polpharma, Tzmo, Eli Lilly And Company, Bristol-Myers Squibb Company, Apotex, Gilead Sciences, Abbvie Inc., Hisun Usa Inc., Glaxosmithkline, Amega Biotech, Biomarin Pharmaceutical, Ferring Pharmaceuticals, Tikun Olam Cannbit, Wavelength Pharmaceuticals, Saudibio, Tabuk Pharmaceuticals, Cipla, Bayer, Adcock Ingram, Johnson & Johnson, Astrazeneca Pharmaceutical (Pty) Ltd., Eurolab, Ranbaxy (Sa) (Pty) Ltd.

North America was the largest region in the global HP (high potency) APIs market in 2023. Middle East is expected to be the fastest growing region in the HP (high potency) APIs market report during the forecast period. The regions covered in the hp (high potency) apis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hp (high potency) apis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The market consists of sales of cytotoxic compounds and sex hormones. Values in this market are factory gate values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

HP (High Potency) APIs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hp (high potency) apis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hp (high potency) apis? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hp (high potency) apis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Innovative HPAPI; Generic HPAPI
  • 2) By Synthesis Type: Synthetic HPAPI; Biotech HPAPI
  • 3) By Therapeutic Application: Oncology; Hormonal Disorder; Glaucoma; Other Therapeutic Applications
  • Companies Mentioned: Merck KGaA; Pfizer, Inc; Thermo Fisher Scientific, Inc; Teva Pharmaceuticals; Lonza Group AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. HP (High Potency) APIs Market Characteristics

3. HP (High Potency) APIs Market Trends And Strategies

4. HP (High Potency) APIs Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global HP (High Potency) APIs Market Size and Growth

  • 5.1. Global HP (High Potency) APIs Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global HP (High Potency) APIs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global HP (High Potency) APIs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. HP (High Potency) APIs Market Segmentation

  • 6.1. Global HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Innovative HPAPI
  • Generic HPAPI
  • 6.2. Global HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Synthetic HPAPI
  • Biotech HPAPI
  • 6.3. Global HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oncology
  • Hormonal Disorder
  • Glaucoma
  • Other Therapeutic Applications (Respiratory Disorders, CVD, Diabetes, Cosmetology, and Erectile Dysfunction)

7. HP (High Potency) APIs Market Regional And Country Analysis

  • 7.1. Global HP (High Potency) APIs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global HP (High Potency) APIs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific HP (High Potency) APIs Market

  • 8.1. Asia-Pacific HP (High Potency) APIs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China HP (High Potency) APIs Market

  • 9.1. China HP (High Potency) APIs Market Overview
  • 9.2. China HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India HP (High Potency) APIs Market

  • 10.1. India HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan HP (High Potency) APIs Market

  • 11.1. Japan HP (High Potency) APIs Market Overview
  • 11.2. Japan HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia HP (High Potency) APIs Market

  • 12.1. Australia HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia HP (High Potency) APIs Market

  • 13.1. Indonesia HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea HP (High Potency) APIs Market

  • 14.1. South Korea HP (High Potency) APIs Market Overview
  • 14.2. South Korea HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe HP (High Potency) APIs Market

  • 15.1. Western Europe HP (High Potency) APIs Market Overview
  • 15.2. Western Europe HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK HP (High Potency) APIs Market

  • 16.1. UK HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany HP (High Potency) APIs Market

  • 17.1. Germany HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France HP (High Potency) APIs Market

  • 18.1. France HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy HP (High Potency) APIs Market

  • 19.1. Italy HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain HP (High Potency) APIs Market

  • 20.1. Spain HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe HP (High Potency) APIs Market

  • 21.1. Eastern Europe HP (High Potency) APIs Market Overview
  • 21.2. Eastern Europe HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia HP (High Potency) APIs Market

  • 22.1. Russia HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America HP (High Potency) APIs Market

  • 23.1. North America HP (High Potency) APIs Market Overview
  • 23.2. North America HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA HP (High Potency) APIs Market

  • 24.1. USA HP (High Potency) APIs Market Overview
  • 24.2. USA HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada HP (High Potency) APIs Market

  • 25.1. Canada HP (High Potency) APIs Market Overview
  • 25.2. Canada HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America HP (High Potency) APIs Market

  • 26.1. South America HP (High Potency) APIs Market Overview
  • 26.2. South America HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil HP (High Potency) APIs Market

  • 27.1. Brazil HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East HP (High Potency) APIs Market

  • 28.1. Middle East HP (High Potency) APIs Market Overview
  • 28.2. Middle East HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa HP (High Potency) APIs Market

  • 29.1. Africa HP (High Potency) APIs Market Overview
  • 29.2. Africa HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. HP (High Potency) APIs Market Competitive Landscape And Company Profiles

  • 30.1. HP (High Potency) APIs Market Competitive Landscape
  • 30.2. HP (High Potency) APIs Market Company Profiles
    • 30.2.1. Merck KGaA
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Pfizer, Inc
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific, Inc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Teva Pharmaceuticals
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Lonza Group AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. HP (High Potency) APIs Market Other Major And Innovative Companies

  • 31.1. Sanofi (EUROAPI)
  • 31.2. Corden Pharma International
  • 31.3. Dr. Reddy's Laboratories Ltd.
  • 31.4. Siegfried Holding AG
  • 31.5. Novartis
  • 31.6. Roche India
  • 31.7. Arlak Biotech (India)
  • 31.8. Healthkind Labs Pvt. Ltd
  • 31.9. Swisschem Healthcare Pvt. Ltd
  • 31.10. Apikos Pharma
  • 31.11. Kolaz Biotech
  • 31.12. Cstone Pharma (China)
  • 31.13. Carsgen Therapeutics (China)
  • 31.14. Jw Therapeutics (China)
  • 31.15. Beigene(China)

32. Global HP (High Potency) APIs Market Competitive Benchmarking

33. Global HP (High Potency) APIs Market Competitive Dashboard

34. Key Mergers And Acquisitions In The HP (High Potency) APIs Market

35. HP (High Potency) APIs Market Future Outlook and Potential Analysis

  • 35.1 HP (High Potency) APIs Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 HP (High Potency) APIs Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 HP (High Potency) APIs Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제